Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Pierre Fabre
Woman and Man Max 99 years
Pierre Fabre (France)
Update Il y a 4 ans
Effect of treatment with L0006CP on the time of fracture-healing
Not provided at time of registration
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by IRPF
Update Il y a 4 ans
Efficacy and safety of Hemangiol solution in the treatment of high risk infantile hemangioma. A Multinational Single Arm Study Eficacia y seguridad de la solución Hemangiol en el tratamiento del hemangioma infantil de alto riesgo. Estudio multinacional con un solo grupo de tratamiento
To document the efficacy of Hemangiol administered during at least 6 months and up to a maximum of 12 months of age in infants with high risk IH. Documentar la eficacia de Hemangiol administrado...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man
Between 18 years and 80 years
Pierre Fabre
Update Il y a 4 ans
Essai de phase 2 évaluant l’efficacité et la tolérance de deux associations thérapeutiques, la combinaison de vinflunine avec gemcitabine et vinflunine avec carboplatine, chez des patients ayant un cancer urothélial à cellules transitionnelles avancé ou métastatique. [essai clos aux inclusions]
L’objectif de cet essai est de comparer deux associations thérapeutiques, la vinflunine et la gemcitabine ou la vinflunine et le carboplatine, chez des patients ayant un cancer urothélial à cellules t...
Country
France
organs
Vessie
,
Rein
,
Appareil urinaire - autres
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Woman and Man Max 99 years
Pierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre
Update Il y a 4 ans
EFFICACY STUDY OF A CICLOPIROXOLAMINE 1% FOAM (DC115 GM 02A) VERSUS CICLOPIROXOLAMINE 1.5% SHAMPOO (SEBIPROX®) IN THE TREATMENT OF MODERATE SEBORRHEIC DERMATITIS OF THE SCALP
To assess the efficacy of a ciclopiroxolamine 1% foam (DC115 GM 02A) versus reference therapy ciclopiroxolamine 1.5% shampoo (SEBIPROX®), on moderate seborrheic dermatitis of the scalp, after 4 weeks ...
Country
None
organs
None
Specialty
None
unknown
More information
Woman Max 99 years
Pierre Fabre Ibérica S.A. as legal representative of Pierr Fabre Mèdicament
Update Il y a 4 ans
Phase II trial of oral vinorelbine in combination with capecitabine as first line therapy in women with previously untreated HER2 negative metastatic breast cancer
To evaluate the Overall Response Rate (ORR) of oral vinorelbine (Navelbine Oral) in combination with capecitabine (Xeloda) for HER2 negative patients.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man Max 99 years
Pierre Fabre Médicament/Institut de Recherche Pierre Fabre
Update Il y a 4 ans
Bronchodilator properties and safety of a repeated dose of V0162 inhalation powder in asthma
To assess the bronchodilator properties of V0162 inhalation powder delivered once daily during 8 days in adult patients with asthma usually treated with ICS and LABA.
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Laboratories (France)
Update Il y a 4 ans
Upward progressive versus degressive compressive stocking in patients with moderate to severe chronic venous insufficiency
Background and study aims Chronic venous insufficiency is a medical condition where the veins cannot pump enough blood back to the heart. The disease mainly occurs in the legs and more commonly affect...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Médicament represented by the Institut de Recherche Pierre Fabre (IRPF)
Update Il y a 4 ans
Effects of F17464 in acute exacerbation of schizophrenia
To evaluate the potential efficacy of 40 mg/day of oral F17464 in comparison to placebo over 6 weeks in patients with acute exacerbation of schizophrenia
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Pierre Fabre Ibérica, S.A
Update Il y a 4 ans
Ensayo clínico en fase I-II de vinorelbina oral (Navelbine) en combinación con capecitabina en tratamiento de primera línea en pacientes con cáncer de mama avanzado
Phase I: Determine the recommended dose, which will be used at the phase II of the trial. Phase II: Determine the overall response of the oral vinorelbine and capecitabine combination.
Country
None
organs
None
Specialty
None
unknown
More information
Woman and Man
Between 18 years and 80 years
Pierre Fabre
Update Il y a 4 ans
Étude L00070IN309F0 : étude de phase 3, randomisée, comparant l’efficacité et la tolérance d’un traitement associant la vinflunine et le méthotrexate par rapport à un traitement par méthotrexate seul, chez des patients ayant un carcinome épidermoïde de la tête et du cou en rechute et/ou métastatique préalablement traité chimiothérapie à base de sels de platine. [essai clos aux inclusions]
L’objectif de cette étude est de comparer l’efficacité et la tolérance d’un traitement associant la vinflunine et le méthotrexate par rapport à un traitement par méthotrexate seul, chez des patients a...
Country
France
organs
Tête et cou
Specialty
Chimiothérapie
Essai clos aux inclusions
More information
Previous
1
2
3
4
5
6
Next